News

Australian researchers have developed an antibacterial coating inspired by insect resilin that shows strong potential for ...
Researchers design a nanovaccine that detects MRSA toxins, kills bacteria with heat, and captures antigens to train the ...
Victorian researchers are improving the treatment of deadly superbugs in a world-first study labelled a “significant” ...
The OxStu discusses the causes and implications of antimicrobial resistance, and the social and scientific methods to combat ...
A protein that gives fleas their bounce has been used to boot out bacteria cells, with lab results demonstrating the material ...
Zevtera, an advanced-generation cephalosporin, is available for treating Staphylococcus aureus bacteremia and 2 other types ...
Antimicrobial-resistant (AMR) “superbugs” contribute to more than 4.5 million deaths globally per year and threaten to make ...
Basilea Pharmaceutica announces commercial availability of antibiotic Zevtera in United States: Allschwil, Switzerland Wednesday, May 21, 2025, 11:00 Hrs [IST] Basilea Pharmaceuti ...
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...
Merab Dvalishvili has built an impressive name for himself as the bantamweight champion since winning the belt when he ...
A deadly superbug that sometimes claims the lives of more than a million people globally a year may have a nemesis that lives right under your nose.
The story of MRSA begins just four years after methicillin entered medical practice in 1959. The bacteria had already developed resistance to the new antibiotic, demonstrating the remarkable ...